Details for New Drug Application (NDA): 085738
✉ Email this page to a colleague
NDA 085738 describes BETAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the BETAMETHASONE SODIUM PHOSPHATE profile page.
The generic ingredient in BETAMETHASONE SODIUM PHOSPHATE is betamethasone sodium phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone sodium phosphate profile page.
The generic ingredient in BETAMETHASONE SODIUM PHOSPHATE is betamethasone sodium phosphate. There are sixty-six drug master file entries for this compound. Additional details are available on the betamethasone sodium phosphate profile page.
Summary for 085738
| Tradename: | BETAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Watson Labs |
| Ingredient: | betamethasone sodium phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
